Meet the Editorial Board Member

Q4 Pharmacology, Toxicology and Pharmaceutics

Current Enzyme Inhibition Pub Date : 2022-07-01 DOI:10.2174/157340801802220825114431

Z. Alothman

引用次数: 0

Abstract

He obtained his Ph.D. in chemistry Oklahoma University in 2006. He is working on a variety of topics ranging from the high surface area materials, Water treatment and production, Ion exchanger, separation and Environmental studies. He is the group leader of Advanced Materials and Chromatography Group and the supervisor of the Advanced Materials Re-search Chair. He supervised seven PhD students and more than 12 master students. He is an author and co-author of more than 350 scientific publications, three books and six patents.

查看原文本刊更多论文

与编辑委员会成员见面

他于2006年获得俄克拉荷马大学化学博士学位。他的研究领域包括高表面积材料、水处理和生产、离子交换器、分离和环境研究等。他是先进材料和色谱组的组长，也是先进材料研究主席的主管。指导博士生7名，硕士生12余名。他是350多篇科学出版物、3本书和6项专利的作者和合著者。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Current Enzyme Inhibition Pharmacology, Toxicology and Pharmaceutics-Drug Discovery

CiteScore

1.30

自引率

0.00%

发文量

期刊介绍： Current Enzyme Inhibition aims to publish all the latest and outstanding developments in enzyme inhibition studies with regards to the mechanisms of inhibitory processes of enzymes, recognition of active sites, and the discovery of agonists and antagonists, leading to the design and development of new drugs of significant therapeutic value. Each issue contains a series of timely, in-depth reviews written by leaders in the field, covering a range of enzymes that can be exploited for drug development. Current Enzyme Inhibition is an essential journal for every pharmaceutical and medicinal chemist who wishes to have up-to-date knowledge about each and every development in the study of enzyme inhibition.